Global Artificial Intelligence In Life Sciences market size is expected to reach $10.43 billion by 2030 at 23.8%, segmented as by software, drug discovery software
Read MoreArtificial intelligence for healthcare payer market to reach USD $6.81 billion by 2030 at 18.6% CAGR, driven by value-based care and data analytics.
Read MoreAI clinical trial protocol feasibility tool market to reach $2.76 billion by 2030 at 27% CAGR, driven by the rising emphasis on precision medicine.
Read MoreAI clinical genomics interpretation market to reach $5.99 billion by 2030 at 28% CAGR, driven by the rising demand for personalized medicine.
Read MoreAI-powered tele-intensive care unit monitoring market to reach $10.58 billion by 2030 at 22.6% CAGR, driven by increase in prevalence of critical illnesses.
Read MoreArtificial intelligence powered spinal surgery market to reach USD $1.66 billion by 2030 at 9.3% CAGR, driven by precision surgery and improved outcomes.
Read MoreAI-powered sleep apnea monitoring market to reach $4.84 billion by 2030 at 21.3% CAGR, driven by rise in obesity and overweight rates.
Read MoreAI-powered rare disease diagnosis market to reach $7.08 billion by 2030 at 28.9% CAGR, driven by increasing prevalence of autoimmune disorders.
Read MoreAI-powered hospital asset rental market to reach $8.05 billion by 2030 at 18.9% CAGR, driven by increasing adoption of asset-as-a-service models.
Read MoreAI-powered dermatology lesion triaging market to reach $4.47 billion by 2030 at 31.8% CAGR, driven by rising prevalence of skin cancer.
Read More